GlassScriptPhysician profile
Christa M Black
NPI 1033177837
$2,910.51
in general payments reported to CMS, 2019-2025
18 companies · $1,173 in 2025
The $1,173 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $117 · 2023: $1,025 · 2024: $596 · 2025: $1,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694 · Education: $98.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,694.37 |
| Education | $98.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,191.02 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $552.79 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Medtronic, INC. | $399.03 | 2023-2025 | Signia |
| Astellas Pharma US INC | $138.32 | 2025 | Veozah |
| Corcept Therapeutics | $112.68 | 2024 | Korlym |
| Rhythm Pharmaceuticals, INC. | $77.46 | 2023-2024 | Imcivree, Imcivree |
| Ethicon US, LLC | $71.71 | 2025 | Echelon Flex, Linx Reflux Management System, Echelon; Endopath |
| Currax Pharmaceuticals LLC | $66.35 | 2022-2025 | Contrave, Nexletol, Nexlizet |
| Vertex Pharmaceuticals Incorporated | $64.22 | 2025 | |
| Abbott Laboratories | $44.45 | 2024 | Freestyle Libre 3 |
| Baxter Healthcare | $44.10 | 2025 | Tisseel |
| Takeda Pharmaceuticals U.S.A., INC. | $29.40 | 2022 | |
| Intra-Sana Laboratories | $28.59 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Fisher & Paykel Healthcare INC | $25.62 | 2023 | Fisher & Paykel Healthcare |
| Pacira Pharmaceuticals Incorporated | $20.94 | 2025 | Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $15.19 | 2022 | |
| Lsi Solutions INC | $14.61 | 2023 | Running Device |
| Redhill Biopharma INC. | $14.03 | 2023 | Talicia, Aemcolo, Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.